Abstract
While sporadic human genetic studies have permitted some comparisons between rodent and human pancreatic development, the lack of a robust experimental system has not permitted detailed examination of human pancreatic development. We previously developed a xenograft model of immature human fetal pancreas grafted under the kidney capsule of immuneincompetent mice, which allowed the development of human pancreatic β-cells. Here, we compared the development of human and murine fetal pancreatic grafts either under skeletal muscle epimysium or under the renal capsule. We demonstrated that human pancreatic β-cell development occurs more slowly (weeks) than murine pancreas (days) both by differentiation of pancreatic progenitors and by proliferation of developing β-cells. The superficial location of the skeletal muscle graft and its easier access permitted in vivo lentivirus-mediated gene transfer with a green fluorescent protein-labeled construct under control of the insulin or elastase gene promoter, which targeted β-cells and nonendocrine cells, respectively. This model of engraftment under the skeletal muscle epimysium is a new approach for longitudinal studies, which allows localized manipulation to determine the regulation of human pancreatic development. © 2013 by the American Diabetes Association.
Cite
CITATION STYLE
Capito, C., Simon, M. T., Aiello, V., Clark, A., Aigrain, Y., Ravassard, P., & Scharfmann, R. (2013). Mouse muscle as an ectopic permissive site for human pancreatic development. Diabetes, 62(10), 3479–3487. https://doi.org/10.2337/db13-0554
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.